These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7238849)

  • 41. [Treatment of severe hypertension with Catapresan. A comparative study of the effects of Catapresan and methyldopa on ambulant hypertensive patients].
    Becker-Christensen F; Bang HO; Ditzel J
    Ugeskr Laeger; 1970 Dec; 132(49):2331-6. PubMed ID: 5488234
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.
    Mori H; Yamamoto H; Ukai H; Yuasa S; Nakajima K; Mikawa T; Niizuma M; Hirao K; Umemura S;
    Hypertens Res; 2013 Mar; 36(3):202-7. PubMed ID: 23013888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of St 155 in chronic renal insufficiency with arterial hypertension].
    Previgliano H; Challu A; Junemann A; Rodano J; Marchand M; Taype E; Gonzalez Ortiz R; Lammirato G; Rodrigues C; Gallardo R; De Felipe C; De la Riestra N
    Prensa Med Argent; 1971 Jul; 58(22):1117-9. PubMed ID: 5097755
    [No Abstract]   [Full Text] [Related]  

  • 44. Heart Failure 99 -- the MOXCON story.
    Coats AJ
    Int J Cardiol; 1999 Oct; 71(2):109-11. PubMed ID: 10574393
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experience in the clinical use of an imidazoline derivative with varying application].
    Teichmann G; Riethling AK; Harms R; Wagner HD; Wedler B; Schröder K
    Dtsch Gesundheitsw; 1970 May; 25(21):971-5. PubMed ID: 5509007
    [No Abstract]   [Full Text] [Related]  

  • 46. Hemodynamic effects of rhomotoxin assessed by impedance cardiography in hypertensive patients.
    Chen G; Gao Y; Mao HY; Li YS
    Chin Med J (Engl); 1985 May; 98(5):325-8. PubMed ID: 3926403
    [No Abstract]   [Full Text] [Related]  

  • 47. Cardiac electrophysiological effects of cibenzoline by acute and chronic administration in the anesthetized dog.
    Sassine A; Massé C; Dufour A; Hirsch JL; Cazes M; Puech P
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):201-18. PubMed ID: 6476979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 49. [On a new hypertensive agent with predominant central action, 2-(2,6-dichlorophenylamino)-2-imidazolinhydrochloride (St 155)].
    van Zwieten PA
    Klin Wochenschr; 1968 Jan; 46(2):77-80. PubMed ID: 5725012
    [No Abstract]   [Full Text] [Related]  

  • 50. The action of tolmesoxide on certain cardiovascular measurements in healthy human volunteers [proceedings].
    Buylla JA; Clifford JM; Wynne RD
    Br J Clin Pharmacol; 1979 Oct; 8(4):402P. PubMed ID: 508540
    [No Abstract]   [Full Text] [Related]  

  • 51. [A new antihypertensive drug: clonidine or Catapressan].
    Amery A; Bossaert H; Deruyttere M; Verstreken G
    Acta Clin Belg; 1969; 24(6):334-55. PubMed ID: 4923381
    [No Abstract]   [Full Text] [Related]  

  • 52. Cardiovascular effects of flutonidin after acute oral administration.
    Mazzola C; Guffanti E; Ferrario N
    Farmaco Prat; 1981 May; 36(5):262-70. PubMed ID: 7238849
    [No Abstract]   [Full Text] [Related]  

  • 53. [New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)].
    Brunner H; Djawan S; Dorda W; Penner E; Grabner G
    Arzneimittelforschung; 1977; 27(8):1599-604. PubMed ID: 334188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypotensive action and side-effects of flutonidin in normal subjects. A double-blind controlled trial.
    Sala P; Chierichetti SM; Ferrari P
    Eur J Clin Pharmacol; 1979; 16(6):375-9. PubMed ID: 393519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison between the effects of ST 600 and catapres.
    Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):347-50. PubMed ID: 1156039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison between the effects of ST 600 and clonidine.
    Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):162-9. PubMed ID: 1190909
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.